Did Bob Gibbs buy Neogenomics stock?

Common questions

Did Bob Gibbs buy Neogenomics stock?

Yes. Bob Gibbs disclosed 1 purchase and 1 sale of Neogenomics (NEO) stock between Dec 19, 2019 and Nov 9, 2021, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

How big were Bob Gibbs's Neogenomics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

Did Bob Gibbs make these Neogenomics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Bob Gibbs still own Neogenomics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Bob Gibbs report these trades?

The latest filing is dated Nov 14, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.